Micafungin Salvage Mono-therapy in Invasive Aspergillosis
Status:
Terminated
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of micafungin in patients with proven invasive
aspergillosis and who are refractory or intolerant to previous systemic antifungal therapy.
To compare the efficacy and safety of the micafungin therapy with the active control arm